- Home
- TBI vs TVGN Comparison
TBI vs TVGN Comparison
Compare TBI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBI
- TVGN
- Stock Information
- Founded
- TBI 1985
- TVGN 2020
- Country
- TBI United States
- TVGN United States
- Employees
- TBI N/A
- TVGN N/A
- Industry
- TBI Professional Services
- TVGN Blank Checks
- Sector
- TBI Consumer Discretionary
- TVGN Finance
- Exchange
- TBI Nasdaq
- TVGN Nasdaq
- Market Cap
- TBI 169.0M
- TVGN 193.1M
- IPO Year
- TBI 1996
- TVGN N/A
- Fundamental
- Price
- TBI $6.95
- TVGN $1.20
- Analyst Decision
- TBI Buy
- TVGN Strong Buy
- Analyst Count
- TBI 1
- TVGN 1
- Target Price
- TBI $10.00
- TVGN $10.00
- AVG Volume (30 Days)
- TBI 222.0K
- TVGN 813.0K
- Earning Date
- TBI 08-04-2025
- TVGN 08-13-2025
- Dividend Yield
- TBI N/A
- TVGN N/A
- EPS Growth
- TBI N/A
- TVGN N/A
- EPS
- TBI N/A
- TVGN N/A
- Revenue
- TBI $1,534,794,000.00
- TVGN N/A
- Revenue This Year
- TBI $0.80
- TVGN N/A
- Revenue Next Year
- TBI $6.90
- TVGN N/A
- P/E Ratio
- TBI N/A
- TVGN N/A
- Revenue Growth
- TBI N/A
- TVGN N/A
- 52 Week Low
- TBI $3.45
- TVGN $0.26
- 52 Week High
- TBI $12.29
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- TBI 68.79
- TVGN 48.04
- Support Level
- TBI $6.08
- TVGN $1.09
- Resistance Level
- TBI $7.35
- TVGN $1.31
- Average True Range (ATR)
- TBI 0.36
- TVGN 0.10
- MACD
- TBI 0.05
- TVGN -0.02
- Stochastic Oscillator
- TBI 85.50
- TVGN 26.19
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.